Geovany Albino de Souza1, Fabio de Castro Bezerra2, Tatiana Duque Martins1. 1. Chemistry Institute, Federal University of Goiás, Av. Esperança, s/n, Vila Itatiaia, BR 74690900 Goiânia, Goiás, Brazil. 2. Physics Institute, Federal University of Goiás, 74690-900 Goiânia, Brazil.
Abstract
In this work, a drug delivery system for perillyl alcohol based on the peptide self-assembly containing 3-(2-benzothiazolyl)-7-(diethylamino)coumarin (C6) as a fluorescent additive is obtained, and its photophysical characteristics as well as its release dynamics were studied by steady-state and time-resolved fluorescence spectroscopy. Results proved the dynamics of drug release from the peptide nanostructures and showed that the system formed by the self-assembled peptide and C6, along with perillyl alcohol, presents unique photophysical properties that can be exploited to generate singlet oxygen (1O2) upon irradiation, which is not achieved by the sole components. Through epifluorescence microscopy combined with time-correlated single photon counting fluorescence spectroscopy, the release mechanism was proven to occur upon peptide structure interconversion, which is controlled by environmental changes.
In this work, a drug delivery system for perillyl alcohol based on the peptide self-assembly containing 3-(2-benzothiazolyl)-7-(diethylamino)coumarin (C6) as a fluorescent additive is obtained, and its photophysical characteristics as well as its release dynamics were studied by steady-state and time-resolved fluorescence spectroscopy. Results proved the dynamics of drug release from the peptide nanostructures and showed that the system formed by the self-assembled peptide and C6, along with perillyl alcohol, presents unique photophysical properties that can be exploited to generate singlet oxygen (1O2) upon irradiation, which is not achieved by the sole components. Through epifluorescence microscopy combined with time-correlated single photon counting fluorescence spectroscopy, the release mechanism was proven to occur upon peptide structure interconversion, which is controlled by environmental changes.
Perillyl alcohol, a monoterpene derived
from limonene, is intensively
studied because of its anticancer properties. It has been successfully
used in brain cancer therapy, administered by intranasal route, because
it improves the drug penetration through the blood–brain barrier[1−3] and in topical administration
for treating skin tumors.[4,5] In addition, the antitumor
activity of perillyl alcohol was reported in a variety of other cancer
cells, such as breast, liver, and pancreatic cancer cells,[6−8] and its antitumor action is related
to its radical scavenging activity, by which reactive oxygen species
(ROS) in the intracellular medium are eliminated.[9] A variety of other mechanisms of action of perillyl alcohol
are reported, related to its penetration to the plasma membrane bilayer
and induced stress in the endoplasmic reticulum,[10] a pro-oxidant effect, involving the disruption of the mitochondria
transmembrane potential that leads to intracellular buildup of ROS,[11] among others.[3,12−18]Nevertheless, the use of perillyl
alcohol has been restricted to the inhalation and topical methods
due to its gastrointestinal side effects incurred by oral administration.[12] An intensively studied strategy that has promised
to optimize drug efficacy is the use of drug delivery systems, which
offer the possibility of drug encapsulation and controlled release
at the desired site for therapeutic action. Drug encapsulation is
responsible for providing in route stability, by avoiding contact
of the drug with the physiological medium, and increased affinity
and permeability to the targeted cells, thereby greatly improving
selectivity, minimizing side effects, and efficacy of the drug, once
a prolonged and sustained release can be achieved at the targeted
location. Drug carrier systems also minimize intoxication by preventing
the spread of the drug in the organism,[4] and, because of this, it is inferred in this work that potential
therapies with perillyl alcohol against tumors in distinct regions
of the organism can be achieved by the use of delivery systems.A variety of these carriers are investigated, such as organic nanoassemblies,[19] micelles,[20] target
receptor nanocarriers,[21] and biopolymer
nano/microparticles[22−24] and
also explored for encapsulation of perillyl alcohol.[4,5] One particularly interesting class of materials researched for drug
delivery is organic supramolecular entities comprising peptide nanostructures.[25−27] Diphenylalanine (Phe–Phe)
nanostructures are protagonists in this class of self-assembling nanomaterials
because of their biocompatibility, their remarkable thermal and chemical
stability,[28,29] and their easily controllable self-assembly
mechanisms, which provide a variety of nanoarchitectures, such as
nanotubes, vesicles, and nanowires, by simply varying the concentration
or modifying the chemical environment.[30−37]Drug delivery systems can be efficiently
combined with photodynamic approaches to result in selective and noninvasive
therapies. Photodynamic therapy (PDT) consists of a local administration
of a photosensitizer, activated by electromagnetic irradiation. Excitation
of the photosensitizer by light triggers photochemical processes that
result in ROS generation, such as superoxide andhydroxide radicals
and molecular oxygen in its singlet electronic excited state, 1O2, which are responsible for the death of tumor
cells only at the vicinity of photosensitizer activation.[38] Allied with drug delivery systems, current third
generation photosensitizers are able to improve even further the efficacy
of the PDT treatments, which also enhance cell assimilation of the
short-lived 1O2.[39]In a previous work,[40a] we have
successfully prepared self-assembled Phe–Phe nanotubes containing
C6, a fluorescent coumarin derivative, as an optical sensor for dissolved
oxygen, which showed improved sensitivity, selectivity, and reproducibility
as compared to the response of the dye alone.[40a] The enhanced sensitivity toward oxygen verified in our
sensor also makes it a potential 1O2 generator
useful for PDT. Also, this work showed that photophysical properties
of coumarin derivatives can be modulated by solvent election and combination
with other materials. Because of this property, a variety of formulations
containing coumarin molecules for PDT have been proposed, some of
which incorporate the benefits of drug delivery systems and anticancer
drugs, aiming a combination of PDT and other therapeutic approaches.[21,41−49] Additionally, several biological
activities of coumarin compounds, including anticancer properties,
are also reported.[50−55]In this work, a peptide-based system for perillyl
alcohol-controlled release is obtained, presenting unique photophysical
properties that enable it to generate singlet oxygen because of the
formation of an exciplex. Herein, we prepared fluorescent Phe–Phe
vesicles doped with coumarin-6 for perillyl alcohol encapsulation,
which also resulted in o, a system with unique photophysical properties
that are not achieved by the sole components, as we demonstrated through
epifluorescence microscopy combined with steady-state and time-resolved
fluorescence spectroscopy. These combined techniques also showed that
drug release is accomplished by induced structural interconversion
of the vesicles to nanotubes by changing the chemical environment
of Phe–Phe assemblies. We also investigated the pro-oxidant
properties of the vesicle system in indirect singlet oxygen measurements,
seeking both drug delivery and PDT applications.
Results and Discussion
The system in study is a combination
of three major components, that is, self-assembled Phe–Phe
vesicles, formed in the presence of a fluorophore, coumarin-6 (C6),
containing perillyl alcohol encapsulation. Such combination results
in unique photophysical characteristics that are the main achievement
of this work. In order to understand the properties of this system,
the sole components as well as their combination two-by-two were also
investigated. Therefore, in this section, Results
and Discussion are presented in terms of the experiments as
they were executed: (1) system preparation to drug release; (2) the
morphological analysis by epifluorescence microscopy and scanning
electron microscopy (SEM); (3) steady-state fluorescence spectroscopy
and time-resolved fluorescence spectroscopy of the system and sole
components, which were analyzed together and in combination with the
microscopic study to understand the photophysical properties of such
system; and (4) singlet oxygen formation by the system, as an unique
property of the system, not characteristic of any of the sole components
or combination two-by-two.
Drug-Controlled
Release Experiments
The kinetics of the release of perillyl
alcohol from the Phe–Phe vesicles were determined by the interpretation
of distinct analytical methods combined together, such as epifluorescence
microscopy, SEM, steady-state fluorescence spectroscopy, and time-resolved
fluorescence spectroscopy. These results are presented separately
for comprehension.
Epifluorescence
Microscopy and SEM
Perillyl alcohol release from Phe–Phe
vesicles was promoted by a chemical environment change, which promotes
the conversion of Phe–Phe vesicles into nanotubes, resulting
in the release of the encapsulated drug. It is achieved by adding
20 μL of a mixture of ethanol/water in the ratio 1:1 to a glass
substrate where Phe–Phe vesicles were previously deposited.
Epifluorescence micrographs were recorded in a time range of 0–105
min, after ethanol/water addition, to investigate the conversion dynamics
from vesicles to nanotubes as it occurs with solvent change. Images
are shown in Figure .
Figure 1
(A–E) Epifluorescence
micrographs recorded during the interconversion dynamics of Phe–Phe
vesicles, obtained at increasing intervals of time, after addition
of the solvent. 200× magnification, scale bar 100 μm. (F)
Scanning electron micrograph of the peptide nanotube in a mixture
of ethanol/water. 5600× magnification, scale bar 2.85 μm.
(A–E) Epifluorescence
micrographs recorded during the interconversion dynamics of Phe–Phe
vesicles, obtained at increasing intervals of time, after addition
of the solvent. 200× magnification, scale bar 100 μm. (F)
Scanning electron micrograph of the peptide nanotube in a mixture
of ethanol/water. 5600× magnification, scale bar 2.85 μm.Figure A
shows the microvesicles obtained in acetone before addition of the
1:1 ethanol/water solvent mixture. Figure B shows smaller vesicles dispersed in the
solvent mixture after 10 min of solvent addition. In contrast to what
is observed in acetone, vesicles tend to gain directionality, a pattern
that is more evident in Figure C, recorded after 20 min from solvent addition, in which vesicles
are more aligned. After 80 min, new growing patterns resembling tubes
can be visualized in Figure D and, as shown in Figure E, nanotubes are numerous after 105 min. A scanning
electron micrograph recorded for Phe–Phe structures grown after
addition of ethanol/water mixture, showed in Figure F, reveals features characteristic of Phe–Phe
microtubes, such as the opened edges of the structure and the hexagonal
symmetry P61.[56]Because
epifluorescence micrographs evidenced the steps of the interconversion
occurring after the environment change, it is possible to infer that
there is a balance of intermolecular forces between the dipeptide
assemblies and the solvent molecules that favors the dipeptide self-assembly
to structures distinct from the vesicles,[30,32,34,35] which are less
stable in this environment than in acetone.Although microscopy
provided the evidence for the interconversion, it is not conclusive
to the drug release approach. In order to corroborate these findings
and prove the perillyl alcohol release, steady-state and time-resolved
fluorescence studies were carried out.
Steady-State Fluorescence
Spectroscopy
Perillyl alcohol
does not show fluorescence and, to perform the steady-state fluorescence
spectroscopy, the fluorophore C6 was added to the perillyl alcohol-containing
Phe–Phe vesicles. If released, perillyl alcohol would interact
with C6, which, in turn, is less polar than the alcohol and interacts
with the nanostructure’s external walls and cannot be located
at the inner portion of the vesicles, leading to a change in the fluorescence
pattern of the fluorophore. The recorded steady-state fluorescence
spectra are shown in Figure A.
Figure 2
(A) Fluorescence
emission spectra of the system submitted to drug release conditions
(λexc. = 330 nm), recorded at a time range of 0–128
min; (B) its intensity ratios of the maximum emission peaks at 505
and 407 nm (I505/I407), with relative standard deviations of 0.001–0.01%.
(C) Fluorescence emission spectra of the control sample: Phe–Phe
vesicles in the absence of perillyl alcohol (λexc = 330 nm), recorded at a time range of 0–120 min; (D) its
intensity ratios of the maximum emission peaks at 505 and 407 nm (I505/I407), with
relative standard deviations of 0.001–0.01%.
(A) Fluorescence
emission spectra of the system submitted to drug release conditions
(λexc. = 330 nm), recorded at a time range of 0–128
min; (B) its intensity ratios of the maximum emission peaks at 505
and 407 nm (I505/I407), with relative standard deviations of 0.001–0.01%.
(C) Fluorescence emission spectra of the control sample: Phe–Phe
vesicles in the absence of perillyl alcohol (λexc = 330 nm), recorded at a time range of 0–120 min; (D) its
intensity ratios of the maximum emission peaks at 505 and 407 nm (I505/I407), with
relative standard deviations of 0.001–0.01%.In Figure A, the fluorescence spectrum recorded before solvent addition
is labeled as time zero (t = 0; black, solid line).
The maximum of fluorescence occurring at 407 nm is characteristic
of the self-assembled dipeptide emission and the maximum at 494 nm
is characteristic of C6.[62] A decrease in
the fluorescence intensity is immediately observed (t = 1 min; red, solid line) after addition of the ethanol/water mixture,
along with a bathochromic shift of 10 nm in C6 fluorescence. This
red-shift indicates a lowering of the electronic excited-state energy,
which is caused by a change in the fluorophore microenvironment upon
addition of a new solvent.[62] Also, a gradual
decrease of the fluorescence intensity of C6 until 36 min is observed,
and then, a fast loss of intensity occurs from 38 min and stabilizes
after 60 min. A hypsochromic shift of 5 nm (from 506 to 501 nm) is
also observed, accompanying the intensity decrease. The fluorescence
peak at 407 nm, on the other hand, does not undergo any significant
change.In order to make a clear assessment of the photophysical
processes acting on each fluorophore in the system, the intensity
ratios of peaks at 505 nm and at 407 nm for each spectrum were calculated,
and they were plotted against time (Figure B). Quenching of C6 emission is proved by
the decrease in the I505/I407 ratio, and it stabilizes at approximately 60 min,
beyond which the relative intensity oscillates, showing that there
is no preferable change in any of the fluorophores of the system.
C6 fluorescence quenching, along with the observed blue-shift until
60 min, shows a progressive association between C6 in the electronic
excited state and another chemical species in the environment, which
shall be the perillyl alcohol gradually released. However, further
time-resolved fluorescence spectroscopy (time-correlated single photon
counting—TCSPC) studies are needed to characterize the formation
of an excited-state complex, and they are presented later on. Also,
some other features of this system may influence C6 photophysical
response and deviate it from the expected, such as fluorophore aggregation
or changes due to Phe–Phe nanostructures interconversion. To
eliminate such influence exerted by aggregation of C6 or Phe–Phe
interconversion, the TCSPC experiment was carried out on a control
sample comprising Phe–Phe vesicles and C6 in the absence of
perillyl alcohol. The recorded fluorescence spectra are presented
in Figure C,D, which
shows a small decrease of intensity of the fluorescence peak at 407
and at 505 nm and an insignificant change in the I505/I407 ratio (Figure D), showing that both fluorophores
exhibit the same behavior. Therefore, there is no suppression of fluorescence
occurring in this control sample that would arise from the energy
transfer process in the electronic excited state, in contrast to that
observed for the system containing the drug. These results show an
exciplex formation with participation of the nonfluorescent perillyl
alcohol, giving rise to distinct exited-state photophysical processes
in the system. Nevertheless, the exciplex needs to be characterized
by time-resolved fluorescence spectroscopy, as we show in further
sections.
Epifluorescence Microscopy
and Steady-State Fluorescence Spectra
Epifluorescence micrographs
and steady-state fluorescence spectra were recorded to enable the
drug release dynamics characterization. For that, the detector of
the spectrofluorimeter was connected to the output of the microscope
using an optical fiber, and fluorescence micrographs and steady-state
fluorescence spectra were obtained from the same region of the sample.Fluorescence micrographs from different regions of the sample,
obtained in increasing intervals of time after addition of water/ethanol,
are shown in Figure . They were recorded using a 420–490 nm excitation filter,
which results in the strong greenish fluorescence of C6. In Figure C–F, patterns
resembling microtubes were observed. Although the change to these
patterns are present in images obtained starting from 20 min after
induction of the interconversion (Figure C), an overall change occurred after 30 min.
It is noteworthy that at 3 min after the addition of the solvent mixture,
vesicles seem to align in order to enable the further structure changes
that are enforced by the changes in environmental polarizability.
Contours are observed in the vesicles, which are not observed in the
first 15 min. These contours are related to the rupture of the larger
vesicles and the coalescence of smaller ones, which might be accompanied
by the release of the perillyl alcohol. In fact, the process start
to occur at the first instant of the solvent addition to the vesicles.
Vesicles immediately align, and from this point, the conversion to
nanotubes takes place.
Figure 3
Epifluorescence
micrographs of Phe–Phe vesicles containing perillyl alcohol
and submitted to the drug release regime (i.e., addition of the ethanol/water
mixture) at (A) the instant of solvent addition; (B) after 15 min
of solvent addition; (C) after 30 min of solvent addition; and (D)
after 90 min of solvent addition. Images obtained under excitation
performed at 420–490 nm. 200× magnification, scale bar
100 μm.
Epifluorescence
micrographs of Phe–Phe vesicles containing perillyl alcohol
and submitted to the drug release regime (i.e., addition of the ethanol/water
mixture) at (A) the instant of solvent addition; (B) after 15 min
of solvent addition; (C) after 30 min of solvent addition; and (D)
after 90 min of solvent addition. Images obtained under excitation
performed at 420–490 nm. 200× magnification, scale bar
100 μm.Steady-state fluorescence spectra obtained
simultaneously to the epifluorescence micrographs were recorded at
the occurrence of the interconversion and are presented in Figure A. Excitation was
performed with the UV excitation filter of the microscope (340–380
nm). Also intensity ratios of peaks at 525 and 407 nm were plotted
against time and are presented in Figure B. These experiments were performed simultaneously,
also with time-resolved fluorescence spectroscopy, which will be discussed
later on.
Figure 4
(A) Fluorescence spectra (λexc = 340–380
nm) of Phe–Phe vesicles containing perillyl alcohol and submitted
to the drug release regime (i.e., addition of ethanol/water mixture)
and (B) I525/I450 intensity ratios, with relative standard deviations of 0.001–0.01%.
(A) Fluorescence spectra (λexc = 340–380
nm) of Phe–Phe vesicles containing perillyl alcohol and submitted
to the drug release regime (i.e., addition of ethanol/water mixture)
and (B) I525/I450 intensity ratios, with relative standard deviations of 0.001–0.01%.An intense fluorescence peak at 450 nm and another
of a lower intensity at 525 nm are observed. In order to study the
interactions of the chromophores of the system with the nonfluorescent
perillyl alcohol, the intensity ratios of these peaks were obtained.
Intensity ratios, shown in Figure B, tend to decrease with time, revealing a progressive
quenching of the band at 525 nm, characteristic of C6; after 30 min
and at 90 min, the intensity of the peak at 450 nm is the highest,
which is due to the patterns resembling grown tubes in Figure D. These findings corroborate
the decrease in the intensity ratio observed from the spectroscopy
measurements alone, discussed in section Steady-State
Fluorescence Spectroscopy, in which a significant quenching
starts at approximately 30 min (Figure D). Thus, drug release is proven by the quenching effect
of the fluorescence at 525 nm, due to an increase in the released
perillyl alcohol concentration with time. Images in Figure showed the interconversion
of Phe–Phe vesicles into nano/microtubes, occurring in the
same time range in which these changes in fluorescence spectra were
detected. Upon vesicle elimination, the released perillyl alcohol
quenches fluorescence of the Phe–Phe/C6 system at 525 nm, which
results in the dark contour feature, better observed in Figure C. In addition, in Martins
et al.[40b] it was shown by fluorescence
spectroscopy and cyclic voltammetry that perillyl alcohol is efficiently
encapsulated by Phe–Phe vesicles.
Time-Correlated Single
Photon Counting
Time-resolved
emission spectra (TRES) experiments were carried out to prove the
role of the perillyl alcohol in the electronic excited-state processes
of the system as well as to identify the groups of fluorophores active
in the system. In this experiments, decay curves are successively
recorded in a range of emission wavelengths, upon the selected excitation
wavelength. The fluorescence decay curves obtained for distinct systems
are shown in Figure , and lifetimes are in Tables –3.
Figure 5
Fluorescence
decay curves recorded during TRES measurements, obtained for (A) sample
1; (B) sample 2; (C) sample 3; (D)sample 4; and (E) sample 5, as they
were described in Table .
Table 1
Fluorescence Lifetimes, Contributions, and
χ2 from TRES Measurements of Sample 2
λ (nm)
τ1 (ns)
τ2 (ns)
τ3 (ns)
χ2
395
6.78 (16%)
1.06 (84%)
1.34
415
4.94 (20%)
0.74 (80%)
1.06
435
9.06 (13%)
2.19 (33%)
0.46 (54%)
1.19
455
9.01 (5%)
2.07 (17%)
0.36 (77%)
1.18
475
10.15 (3%)
2.26 (28%)
0.32 (68%)
1.22
495
2.38 (69%)
0.29 (31%)
1.19
515
2.35 (57%)
0.34 (43%)
1.29
535
2.35 (57%)
0.34 (43%)
1.52
Table 3
Fluorescence Lifetimes, Contributions, and χ2 from
TRES Measurements of Sample 1
λ (nm)
τ1 (ns)
τ2 (ns)
τ3 (ns)
χ2
395
5.61 (27%)
1.24 (73%)
1.08
415
6.23 (22%)
1.39 (78%)
1.14
435
7.26 (7%)
1.86 (22%)
0.34 (71%)
0.98
455
7.26 (7%)
1.86 (22%)
0.34 (71%)
1.16
475
2.54 (59%)
0.31 (41%)
1.24
495
2.44
1.54
515
2.52
1.20
535
2.50
1.12
Fluorescence
decay curves recorded during TRES measurements, obtained for (A) sample
1; (B) sample 2; (C) sample 3; (D)sample 4; and (E) sample 5, as they
were described in Table .
Table 6
Description of the Samples Studied by Time-Resolved
Fluorescence Spectroscopya
Phe–Phe vesicles + PA + C6 in acetone, after
addition of ethanol/water
3
Phe–Phe nanotube (PNT) + C6 without perillyl
alcohol in ethanol/water
4
C6 in acetone
5
C6 in acetone after addition of ethanol/water
Determination of singlet oxygen O21.
From fluorescence lifetimes (Tables –3), fluorescence decays
are biexponential from 395 to 415 nm, the characteristic region of
emission of Phe–Phe structures. As longer emission wavelengths
are monitored, a multiexponential behavior is adopted by the system,
from 435 to 475 nm, which is the evidence for the presence of more
than one fluorescent moiety contributing to the total decay. At this
emission region, there is no efficient emission of either one of the
Phe–Phe/C6 system-isolated participants. Emission, thus, must
be from an exciplex formed between the Phe–Phe structure and
C6, resulting in the multiexponential decay recorded at this region.It is known that the dispersion forces responsible for the dipeptide
conjugation and stability of the Phe–Phe assemblies give rise
to unique photophysical properties.[63,64] Thus, it is
expected that the structural transition caused by the structure interconversion
would result in a distinct photophysical behavior, as vesicles are
stabilized by end–group interactions and tubular assemblies
of the hexagonal symmetry are held together by π-stacking and
solvent interactions.[31,33,35] However,
in an aqueous environment, both structures (vesicles and tubes) are
present, as shown previously by the epifluorescence micrographs (Figure ) because the self-assembly
process is thermodynamically driven by a delicate balance of noncovalent
interactions between the solvent molecules and the peptide moieties,
resulting in a configuration of minimum free energy.[33,35,36] Comparing lifetimes obtained
for partial systems (Table ), it is possible to relate them to the lifetimes obtained
for the whole system and characterize an exciplex, if formed, between
all components of the system (Table ). At all samples, at the range from 395 to 415 nm,
which corresponds to the emission range of Phe–Phe structures,
the longer lifetime contributes with 20% in average to the total decay
curve, whereas the shorter lifetime corresponds to 80%. Longer lifetimes
are of 3.5 ns for the nanotube sample (Table ) and are of 5–6 ns for vesicle samples
(Tables and 3). Nevertheless, shorter lifetimes are very similar
in sample 2, which is Phe–Phe vesicles containing C6 and PA,
in the presence of the ethanol/water mixture, as showed in Table , and sample 3 (Phe–Phe
nanotubes, containing C6, after PA release), being 0.74–1 ns
(Tables and 2); whereas they are around 1.2–1.4 ns in
the sample of Phe–Phe vesicles loaded with perillyl alcohol
(Table ). As longer
wavelengths are monitored, decay curves became multiexponential for
all systems and become biexponential again from 495 to 515 nm, which
corresponds to a region at only C6 is emitting. Therefore, the region
from 435 to 475 nm is related to the exciplex emission region. In
this region, the longer lifetimes become even longer at all samples,
being 6–7 ns in sample 1 (Table ), which consists of the complete system, kept in acetone
and in sample 3 (Table ), which has no PA, and is in the presence of the ethanol/water mixture,
but it is 9–10 ns in the complete system, prepared in acetone,
which had received the ethanol/water mixture to convert into nanotubes.
Nevertheless, these longer lifetimes contribute with less than 10%
to the total decay curve. Major components are the shorter wavelengths
that arise at this emission region of 0.4–0.5 ns and contributing
with around 70% to the total decay curve and an intermediary lifetime
of around 2 ns and presenting 20–30% of contribution to the
total decay curve is observed at all samples. From region from 495–515
nm, which corresponds to the emission region of the fluorophore and
no emission from Phe–Phe structures is expected, a biexponential
behavior is again observed. Lifetimes recorded are again around 2
ns with 30% of the contribution and 0.3–0.7 ns, contributing
with around 70% to the total decay curve. Interestingly, curves obtained
for the vesicles loaded with perillyl alcohol (prior to drug release)
are monoexponential at this emission region (Table ), with lifetimes of 2 ns as well. Despite
perillyl alcohol does not present fluorescence, it is involved in
the exciplex formation; these findings reveal that perillyl alcohol
plays an important role in the photophysical properties of the self-assembled
dipeptide, which results in stabilization of electronic excited states
of the system.
Table 2
Fluorescence Lifetimes, Contributions, and χ2 from
TRES Measurements of Sample 3
λ (nm)
τ1 (ns)
τ2 (ns)
τ3 (ns)
χ2
395
3.43 (14%)
0.76 (86%)
1.28
415
3.30 (21%)
0.74 (79%)
1.12
435
6.18 (4%)
1.75 (24%)
0.50 (71%)
1.05
455
6.21 (3%)
1.61 (17%)
0.38 (79%)
1.05
475
6.84 (6%)
2.14 (35%)
0.44 (58%)
1.08
495
2.63 (64%)
0.48 (36%)
1.38
515
2.66 (70%)
0.60 (30%)
1.20
535
2.71 (68%)
0.61 (32%)
1.16
From these data, the electronic excited state
of the complexes formed between the Phe–Phe structures and
C6 presents their activity at the emission region of 435–475
nm, being stabilized as longer wavelengths are observed. The emission
from C6 that are not part of the complex can still be observed, resulting
in shorter lifetimes. To evaluate the possibility of complex formation,
these lifetimes are compared to those obtained from C6 solutions in
acetone, the chosen solvent to prepare vesicle and a good solvent
for C6 and the ethanol/water 1:1 mixture, the solvent chosen to promote
interconversion. In these conditions, the photophysical behavior of
the fluorophore alone can be interpreted and compared to the response
obtained from the system. Data obtained for C6 solutions are shown
in Table .
Table 4
Fluorescence Lifetimes, Contributions, and χ2 from TRES Measurements of Samples 4 and 5
sample 4
sample 5
λ (nm)
τ1 (ns)
τ2 (ns)
χ2
τ1 (ns)
τ2 (ns)
τ3 (ns)
χ2
435
2.21 (23%)
0.78 (77%)
1.03
2.52 (22%)
0.63 (78%)
1.48
455
2.62 (37%)
0.94 (63%)
1.06
8.17 (4%)
1.88 (24%)
0.49 (71%)
1.18
475
2.52
1.18
5.50 (6%)
1.82
(40%)
0.21 (53%)
1.18
495
2.53
0.91
2.30 (79%)
0.36 (21%)
1.06
515
2.53
1.02
2.28 (83%)
0.47 (17%)
1.13
535
2.53
1.12
2.34 (69%)
0.46 (31%)
1.05
Table shows monoexponential
decays for emission from 475 nm for C6 in acetone (sample 4, left
columns), with lifetimes of 2.5 ns, which are similar to those of
the vesicles system containing perillyl alcohol (sample 1, Table ). Upon ethanol/water
mixture addition (sample 5, right columns), decays become biexponential,
with lifetimes of 2.3 and 0.3 ns, contributing with 80 and 20% to
the total curve, respectively. Similar to that observed for vesicles,
after addition of the solvent (sample 2, Table ), decays also become biexponential and present
similar lifetime values of τ1 (around 2.3 ns), which
correspond to the contribution of C6 aggregates formed upon dilution
with ethanol/water. However, when comparing these results to those
of the self-assembled system without perillyl alcohol (Table ), prepared in the same chemical
environment of the drug release (Table ), lifetimes recorded at the spectral range of C6 (435–535
nm) are higher in the control sample (Table ), which indicates the occurrence of a nonradiative
electronic energy transfer between the released perillyl alcohol and
C6. Interestingly, the characteristic fluorescence lifetime of C6
in acetone, of around 2.5 ns (Table ), is similar to those of the complete vesicle system,
in acetone, prior to drug release (Table ), recorded in the same spectral range, which
further supports a stronger influence of the perillyl alcohol only
after the release event.
Generation
of Singlet Oxygen
In a previous photophysical study of the
Phe–Phe/C6 system,[40] it was inferred
that this system could generate singlet oxygen,1O2, upon irradiation with light of a proper wavelength, aiming new
applications of this drug delivery system, such as PDT.To determine
its ability to generate 1O2, the indirect method
for determination of 1O2 quantum yield, employing
uric acid (UA) as the 1O2 sensor is used, which
has proven to be a reliable, accurate, and low-cost method.[59−61,65,66] By this method, the solution containing
the vesicle system and UA was irradiated at 450 nm, which is the maximum
absorption wavelength of the system, and electronic absorption spectra
were recorded in intervals from 0 to 1320 s (Figure A). As control measurements, spectra were
also recorded in similar experiments containing the Phe–Phe
structure (Figure B); C6 (Figure C);
perillyl alcohol (Figure D); a combination of C6 and perillyl alcohol (Figure E); and a combination of C6
and Phe–Phe structure (Figure F). The determination of 1O2 quantum
yield is carried out by evaluating the intensity decrease of the UAabsorption peak at 287 nm.
Figure 6
Absorption spectra of UA in the presence of
(A) sample 6; (D) sample
7; (F) sample 8; and (H) sample 9, with time of irradiation from 0
to 1380 s and of (J) sample 10; (K) sample 11; (L) sample 9; and (M)
sample 12, with time of irradiation from 0 to 110 s. Samples were
described in Table . λexc = 650 nm for methylene blue (MB) standard
and λexc = 450 nm for systems. Inserts show zoomed
images of the absorption peaks. Plots of absorption vs time of (B)
sample 6; (E) sample 7; (G) sample 8; and (I) sample 9 and (C) plot
of Ln (absorption) vs time of sample 6.
Absorption spectra of pan class="Chemical">UA in the presence of
(A) sample 6; (D) sample
7; (F) sample 8; and (H) sample 9, with time of irradiation from 0
to 1380 s and of (J) sample 10; (K) sample 11; (L) sample 9; and (M)
sample 12, with time of irradiation from 0 to 110 s. Samples were
described in Table . λexc = 650 nm for methylene blue (MB) standard
and λexc = 450 nm for systems. Inserts show zoomed
images of the absorption peaks. Plots of absorption vs time of (B)
sample 6; (E) sample 7; (G) sample 8; and (I) sample 9 and (C) plot
of Ln (absorption) vs time of sample 6.
Table 7
Description
of Samples Produced to Investigate Pro-oxidant Activity
In Figure A, the absorption spectra of pan class="Chemical">UA in the presence
of the 1O2 standard generator,MB, are shown.
A fast decrease in the absorption of UA at 280 nm occurs within 100
s of irradiation, a result of high concentrations of 1O2 produced by the MB standard. In Figure D–H, in which the absorption of UA
in the presence of the vesicle system and its isolated components
are shown, photodegradation of UA also occurs in the presence of Phe–Phe
vesicles containing C6 and perillyl alcohol (sample 7), the Phe–Phe/C6
system (sample 8) and fluorophore alone (sample 9), however, with
distinct rates.
For the control samples shown in Figure J–M, in which the effect
of the isolated compounds over the absorption of the sensor pan class="Chemical">UA is
evaluated, no significant changes were observed at the absorption
wavelength related to UA (280 nm), which was expected because it is
known that both Phe–Phe and the perillyl alcohol exhibit antioxidant
properties.[13,67]Figure M also shows that the combination of C6 and
perillyl alcohol presents no effect in the absorption of UA as well,
which demonstrates that the oxidant effect as shown in Figure D can be only achieved by the
system composed of Phe–Phe, C6 and perillyl alcohol, even though
the isolated components are not able to promote UA degradation. In
order to prove this synergistic effect and to relate it to the formation
of an electronic excited-state complex that culminates with the increase
of the 1O2 generation, 1O2 formation quantum yields, ΦΔ, were calculated
by an indirect method using MB as standard. According to Rabello et
al.[60] UA undergoes a biexponential, two-step
first-order degradation kinetics, in which the first step is characterized
by the reaction of UA with 1O2,and the second
step related to an intermediate product, which can be identified by
its increasing absorption at 390 nm. In this mechanism, however, only
the first-step kinetic constant is suitable for ΦΔ calculation. The rate constant of UA photodegradation is extracted
from the linear relationship between the natural logarithm of UAabsorption
at 290 nm and irradiation time.
For the sample of UA with the
MB standard, which is the appropriate model for ΦΔ determination, prepared in the ethanol/water solvent system, the
plot of absorption of UA versus irradiation time is exponential, as
expected (Figure B).
However, a linear fitting of the natural logarithm of absorption was
unsuccessful (Figure C), which is due to solvation effects and the rate of diffusion of 1O2, factors that are affected by the chemical environment,
ultimately reflecting in the degradation kinetics. For the systems
of interest of this work, the plots of the absorption resulted in
a linear relationship (Figure D through 6I) and were used for ΦΔ determination.The respective UA photodegradation
kinetic constants used in ΦΔ calculations and
ΦΔ values are shown in Table .
Table 5
Photodegradation
Kinetic Constants of UA, Autocorrelation Parameters (R2), and ΦΔ Values Obtained for
the Samples Combined to UA. MB is the Control
sample
kinetic constant k (s–1)
R2
equation
ΦΔ (%)
6
5.85 × 10–3
0.992
[Abs.]t = [Abs.]0 + [Abs.]0e–kt
52 (in
ethanol) [ref (68)]
7
3.24 × 10–4
0.992
[Abs.]t = [Abs.]0 – kt
3.07
8
1.35 × 10–4
0.990
[Abs.]t = [Abs.]0 – kt
0.82
9
1.30 × 10–4
0.997
[Abs.]t = [Abs.]0 – kt
0.71
As showed in Table , ΦΔ of the Phe–Phe/C6
system is slightly higher than that of C6. However, the value of ΦΔ obtained from the Phe–Phe/C6/PA vesicle system
is significantly higher than that of the C6 control sample. These
results demonstrate that the association of self-assembled Phe–Phe
with C-6 and perillyl alcohol yields a product of distinct electronic
excited-state dynamics, characterized by the formation of the exciplex
mentioned earlier, which improves the pro-oxidant activity inherent
of the fluorophore.Based on the steady-state and time-resolved
fluorescence spectroscopy data, presented in the previous sections,
it is implied that the mechanism of action of such exciplex involves
its nonradiative deactivation. It concerns the intersystem crossing
to populate the triplet electronic excited state of the complex, a
process otherwise negligible in the isolated compounds, which is a
requirement for conversion of oxygen to its reactive singlet electronic
excited state, responsible for the PDT activity. The electronic energies
involved in the proposed mechanism is shown in Scheme .
Scheme 1
Illustration of the
Photophysical Processes of the Exciplex Phe–Phe/C6/PA Deactivation
and the Production of 1O2
These results show that the vesicle
system formed by the C6 fluorophore, perillyl alcohol, and Phe–Phe
structure presents unique photophysical properties that enables it
to be used as a drug delivery system with potential to generate 1O2 and, therefore, with potential for PDT applications.
This opens great perspectives to the uses of perillyl alcohol to fight
cancer because it is well-known that this compound is a potent drug
that exerts cancer preventive and therapeutic activity in a variety
of tumors, such gliomas, lung, and upper respiratory tumor, but the
actual difficulties are faced to administer this drug prevent it from
being widely used. In fact, until now, only administration by inhalation
has proved satisfactory. With the perspective of encapsulation and
its use in PDT, proved in this work, new possibilities of treatments
based on perillyl alcohol use, can be considered.
Conclusions
The drug delivery system for
perillyl alcohol based on self-assembled peptides containing C6 as
a fluorophore described herein presented a prolonged and sustained
release of perillyl alcohol because it was extended to over an hour.
It is achieved via an induced disruption of the vesicles by simple
modifications of environmental properties. The fluorescent additive,
C6, was successfully used as the fluorescent probe to study the dynamics
of drug release, but it also takes part, along with perillyl alcohol,
in interesting photophysical processes favored by the exciplex formation
involving the components of the system, as proved by TCSPC. Such photophysical
processes are responsible for the enhanced pro-oxidant activity presented
by this system, which is important for PDT applications.In
addition, the drug delivery system can extend the anticancer activity
of perillyl alcohol to more than a single therapeutic approach, that
is, a system that can be the combination of the antitumor properties
of the encapsulated perillyl alcohol, and when activated by light,
it can act as a photosensitizer in PDT or even be useful in combined
therapy of both approaches.
Materials
and Methodology
1,1,1,3,3,3-Hexafluoro-2-isopropanol (HFIP),
CAS no. 920-66-1; pan class="Chemical">l-diphenylalanine (Phe–Phe), CAS
no. 2577-40-4; 3-(2-benzothiazolyl)-7-(diethylamino)coumarin (coumarin-6)
CAS no. 38215-36-0; and perillyl alcohol, CAS no. 18457-55-1, purchased
from Sigma-Aldrich, were used as received. Figure S1 in the Supporting Information presents their structures.
Preparation
of Phe–Phe Vesicles and
Drug Encapsulation
Phe–Phe (Sigma-Aldrich, M = 241.11 g mol–1) vesicles containing
perillyl alcohol (Sigma-Aldrich, d = 0.96 g cm–3; M = 152.23 g mol–1) were prepared by dissolving 10 mg of the lyophilized dipeptide
(4.0 × 10–2 mmol) and 6 mg of perillyl alcohol
(4.0 × 10–2 mmol) in 50 μL of HFIP (Sigma-Aldrich,
99.8% pure, M = 168.05 g mol–1).
This fresh solution was diluted in a 10–6 mol L–1 solution of C6 (Sigma-Aldrich) in acetone, resulting
in a solution of final peptide concentration within the range of 1–2
g L–1 and a proportion of 10–5 mmol of C6 to 4 × 10–2 mmol of Phe–Phe.
In acetone, the dipeptide spontaneously assembles in nano/microvesicles,
encapsulating the perillyl alcohol. These concentrations were used
in accordance to previous works.[29−32,40,69,70]
Drug Release Experiments
Perillyl
alcohol-controlled release from the peptide vesicles was evaluated
by epifluorescence microscopy combined with steady-state and time-resolved
fluorescence spectroscopy, as described below.
Epifluorescence Microscopy
Epifluorescence micrographs
were recorded in a Leica DMIRBE inverted microscope, using 200×
magnification objective lenses and 340–390 nm and 420–490
nm excitation filters. Micrographs were recorded from liquid samples
to follow the Phe–Phe self-assembled interconversion at solvent
polarizability changes.Micrographs were recorded from the initial
solution deposited on a glass substrate, at a time marked as zero
for drug release, followed by the addition of 20 μL of a mixture
of 1:1 of ethanol and water. At the same time, micrographs were recorded
from several regions of the sample with time control of each shot,
to monitor the interconversion kinetics. Based on our previous studies,[40] water alone is sufficient to promote interconversion;
however, a mixture of ethanol and water at neutral pH was added to
the dried sample, to promote C6 and perillyl alcohol dissolution.
At each time interval, an aliquot was taken and deposited in a glass
substrate to perform electron scanning microscopy (SEM) studies.
Electron Scanning Microscopy
SEM images were obtained in
a JEOL scanning electron microscope,
model JSM 6610, equipped with a Thermo Scientific NSS Spectral Imaging.
Images were acquired at a spot size set at 40 mm, work distance at
14 mm, and with an accelerated voltage of 4 keV. A volume of 20 μL
of the freshly prepared vesicles dispersed in acetone was deposited
onto a glass substrate, and the solvent was evaporated in an oven
at 40 °C for 48 h. Samples were placed in a copper sample holder,
and metallization was carried out in a Bal-Tec MED 020 sputtering
chamber.
Steady-state spectroscopy was performed
in a Horiba Fluoromax 4 spectrofluorimeter, equipped with a pan class="Chemical">xenon
lamp. A sample holder for
cuvettes adapted for solid samples was used to place liquid samples
in position for fluorescence detection at 90° and in solid samples,
to place them in a 45° right-angle with respect to the incident
radiation. Fluorescence was detected at the range of 250–850
nm. Narrow slits were employed to ensure resolution of 0.50 nm in
measurements. A volume of 2 mL of the self-assembled system dispersed
in acetone was placed in a quartz cuvette and had its fluorescence
spectrum recorded, at distinct periods of time. This recording marked
the time as zero. Then, the same volume of an ethanol/water mixture
of 1:1 was added, and the fluorescence intensity of the band at 500
nm was monitored by recording successive fluorescence spectra in increasing
intervals.
Time-resolved spectroscopy was
performed in an Edinburgh Instruments F900 TCSPC Analytical spectrophotometer,
equipped with an Edinburg Hamamatsu R3809U-50 TCSPC detector and a
351 nm pulsed LED of 77 ps of pulse width. An excitation and emission
slit aperture of 1 mm was used. Samples were sealed in quartz cuvettes
and placed in the sample holder to register the fluorescence lifetimes.
Data of the sample signal over the instrumental response were deconvoluted
and analyzed by the exponential series method.[57] Ludox (Sigma-Aldrich) was used as the scatterer. Experimental
data correspond to expected theoretical values when χ2 is close to 1.TRES experiments were performed for the samples
described in Table . Fluorescence decay curves were recorded in the spectral range from
370 to 520 nm, with a 20 nm step. The decay data were analyzed in
Fluortools Decayfit free software, v. 1.4.[58]Determination of singlet oxygen O21.Samples compositions are presented in Table .In the pro-oxidant activity assessment,
UA was used as the O21 sensor.[59,60] UA was dissolved in 2 mL of 1:1 of ethanol and water mixture to
result in an absorbance between 1.0 and 1.8. Phe–Phe vesicles
were dispersed in 2 mL of UA solution of UA and in a quartz cuvette.
The sample was irradiated with the appropriate excitation source at
increasing intervals of time. After each irradiation, absorption spectra
were recorded in a Hitachi U2900 spectrophotometer. The absorption
intensity decrease of UA was monitored at 290 nm. This experimental
protocol was repeated for samples listed in Table , with excitation at 650 nm (100 mW Laserline
Izi laser source) for sample 1, and for samples 2–6, excitation
was carried out at 450 nm using a portable array of 20 mW LEDs assembled
at the laboratory. Samples compositions, prepared for these experiments,
are presented in Table .Oxygen singlet (1O2) quantum yield
(ΦΔ(fs)) was indirectly determined using MB
as standard.[59,60] Quantum yield was calculated
by eq (61)In which,
ΦΔ(fs) and ΦΔ(0) are 1O2 quantum yield of the system under study and
of the MB standard, respectively; k(fs) and k(0) are the photodegradation rates of UA in the presence
of the system and MB, respectively; E(λ) is
the emission spectra recorded upon excitation at wavelengths λ1 e λ2; Abs·(fs); and Abs·(0) are
the absorptions of the system and MB, respectively. The rates of UA
photodegradation by 1O2 were obtained from the
slope of the plot of UAabsorption intensity at 287 nm versus irradiation
time.
Authors: Aline C Gomes; Angélica L Mello; Manuel G Ribeiro; Diogo G Garcia; Clovis O Da Fonseca; Marcela D'Alincourt Salazar; Axel H Schönthal; Thereza Quirico-Santos Journal: Arch Immunol Ther Exp (Warsz) Date: 2017-03-17 Impact factor: 4.291
Authors: Hee-Yeon Cho; Weijun Wang; Niyati Jhaveri; Shering Torres; Joshua Tseng; Michelle N Leong; David Jungpa Lee; Amir Goldkorn; Tong Xu; Nicos A Petasis; Stan G Louie; Axel H Schönthal; Florence M Hofman; Thomas C Chen Journal: Mol Cancer Ther Date: 2012-08-28 Impact factor: 6.261
Authors: Clovis O da Fonseca; Marcela Simão; Igor R Lins; Regina O Caetano; Débora Futuro; Thereza Quirico-Santos Journal: J Cancer Res Clin Oncol Date: 2010-04-18 Impact factor: 4.553
Authors: Antonio C C Ribeiro; Geovany A Souza; Douglas Henrique Pereira; Diericon S Cordeiro; Ramon S Miranda; Rogério Custódio; Tatiana D Martins Journal: ACS Omega Date: 2019-01-09